Goldline Pharmaceutical schedules 22nd AGM for August 29, 2026
Goldline Pharmaceutical Limited will hold its 22nd AGM on August 29, 2026, in Nagpur. Remote e-voting is available from August 25 to August 28, 2026, via Bigshare Services. The record date for voting eligibility is August 22, 2026, and the share transfer books will be closed from August 23 to August 29, 2026.

*this image is generated using AI for illustrative purposes only.
Goldline Pharmaceutical Limited has scheduled its 22nd Annual General Meeting (AGM) for Saturday, August 29, 2026, at 4:00 PM. The meeting will take place at Hotel Airport Centre Point, located at 131/1, Wardha Road, Somalwada, Nagpur, Maharashtra. This convening ensures shareholders can address and vote on the business items detailed in the notice issued on Thursday, August 6, 2026, while complying with the Companies Act, 2013, and SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
The company is facilitating remote e-voting to enable broader shareholder participation. Pursuant to Section 108 of the Companies Act, 2013, read with Rule 20 of the Companies (Management and Administration) Rules, 2014, and Regulation 44 of the SEBI LODR Regulations, Goldline Pharmaceutical has engaged Bigshare Services Private Limited as the agency for providing the remote e-voting facility. Shareholders may cast their votes electronically via the Bigshare website.
Key Dates for Shareholders
The following timeline governs the eligibility and voting process for the AGM:
| Event | Date | Time |
|---|---|---|
| Record Date (Cut-off) | Saturday, August 22, 2026 | — |
| Register Closure Begins | Sunday, August 23, 2026 | — |
| Remote E-Voting Starts | Tuesday, August 25, 2026 | 9:00 AM |
| Remote E-Voting Ends | Friday, August 28, 2026 | 5:00 PM |
| AGM Meeting Date | Saturday, August 29, 2026 | 4:00 PM |
Only shareholders whose names appear in the Register of Members or the Register of Beneficial Owners maintained by depositories as of the cut-off date, August 22, 2026, are entitled to vote. The Register of Members and Share Transfer Books will remain closed from Sunday, August 23, 2026, to Saturday, August 29, 2026, both days inclusive, to facilitate this record.
E-Voting Mechanism and Guidelines
Shareholders have two options for voting: remote e-voting prior to the meeting or voting through a ballot form/polling paper during the physical meeting. However, a member can opt for only one mode. If a member casts votes through both channels, the e-vote will prevail, and the ballot vote will be treated as invalid. Those who have already voted remotely may attend the meeting but cannot vote again.
The notice for the AGM was sent electronically on August 6, 2026, to shareholders with registered email IDs. For those who did not receive the email or lack registered contact details, login credentials can be generated by following instructions in the 'Notes' section of the AGM notice available on the company’s website or the stock exchange portal. Physical shareholders must update their email and mobile number with their respective Depository Participants to ensure they receive future communications and can participate in e-voting.
What This Means for Investors
The closure of the share transfer books between August 23 and August 29 means no share transactions will be processed during this period for the purpose of determining voting rights. Investors looking to acquire shares for voting eligibility must do so before the record date. Conversely, those wishing to divest should note that while transfers are blocked, the market price may reflect any expectations surrounding the agenda items to be discussed at the AGM. The availability of remote e-voting reduces the friction for institutional and retail investors to exercise their corporate governance rights without needing physical presence in Nagpur.
Historical Stock Returns for Goldline Pharmaceutical
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.51% | +2.22% | -3.30% | -27.78% | -27.78% | -27.78% |
What specific agenda items or resolutions are expected to be discussed at the AGM that could significantly impact Goldline Pharmaceutical's strategic direction?
How might the outcome of shareholder votes on key governance issues influence investor confidence and the stock's valuation in the near term?
Are there any pending regulatory approvals or compliance matters related to SEBI LODR regulations that Goldline needs to address following this AGM?





























